Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 24, 2019

Primary Completion Date

July 2, 2019

Study Completion Date

August 29, 2019

Conditions
Glaucoma
Interventions
DRUG

PRO 179

"* Generic name: Travoprost~* Distinctive denomination: Bristrio® (PRO-179)~* Active principles: Travoprost 0.004%.~* Pharmaceutical form: Ophthalmic solution~* Presentation: multi-dose dropper bottle, 2.5 milliliters.~* Prepared by: Sophia Laboratories, S.A. of C.V.~* Description of the solution: transparent solution, free of visible particles.~* Description of container: White bottle with 5 milliliters capacity, made of low density polyethylene."

DRUG

Travatan 0.004 % Ophthalmic Solution

"* Generic name: Travoprost~* Distinctive denomination: Travatan®~* Active ingredients: Travoprost 0.004%~* Pharmaceutical form: Ophthalmic solution.~* Presentation: multi-dose dropper bottle, 2.5 milliliters.~* Prepared by: Alcon Laboratories Inc.~* Description of the solution: transparent solution, free of visible particles.~* Consult information to prescribe."

Trial Locations (1)

45160

Jose Navarro Partida, Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT03965052 - Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® | Biotech Hunter | Biotech Hunter